COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - EPA:CRI - FR0000130692 - Common Stock
9.82 EUR
+0.04 (+0.41%)
We assign a fundamental rating of 3 out of 10 to CRI. CRI was compared to 17 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of CRI have multiple concerns. CRI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year CRI was profitable.
CRI had a positive operating cash flow in the past year.
CRI had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CRI reported negative operating cash flow in multiple years.
1.2 Ratios
CRI has a Return On Assets of 0.26%. This is in the lower half of the industry: CRI underperforms 70.59% of its industry peers.
Looking at the Return On Equity, with a value of 0.96%, CRI is doing worse than 70.59% of the companies in the same industry.
CRI has a Return On Invested Capital (5.19%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for CRI is below the industry average of 6.93%.
The last Return On Invested Capital (5.19%) for CRI is above the 3 year average (4.65%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROIC | 5.19% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
Looking at the Profit Margin, with a value of 0.34%, CRI is doing worse than 70.59% of the companies in the same industry.
CRI's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.46%, CRI perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
In the last couple of years the Operating Margin of CRI has remained more or less at the same level.
Looking at the Gross Margin, with a value of 28.51%, CRI is doing worse than 82.35% of the companies in the same industry.
CRI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
CRI has more shares outstanding than it did 1 year ago.
CRI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CRI has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.23, we must say that CRI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CRI (1.23) is worse than 82.35% of its industry peers.
CRI has a debt to FCF ratio of 131.84. This is a negative value and a sign of low solvency as CRI would need 131.84 years to pay back of all of its debts.
CRI has a Debt to FCF ratio of 131.84. This is in the lower half of the industry: CRI underperforms 64.71% of its industry peers.
A Debt/Equity ratio of 1.38 is on the high side and indicates that CRI has dependencies on debt financing.
With a Debt to Equity ratio value of 1.38, CRI perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Altman-Z | 1.23 |
ROIC/WACC0.81
WACC6.4%
2.3 Liquidity
CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
CRI's Current ratio of 1.30 is on the low side compared to the rest of the industry. CRI is outperformed by 88.24% of its industry peers.
A Quick Ratio of 0.86 indicates that CRI may have some problems paying its short term obligations.
The Quick ratio of CRI (0.86) is worse than 64.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 146.24% over the past year.
The earnings per share for CRI have been decreasing by -14.59% on average. This is quite bad
Looking at the last year, CRI shows a small growth in Revenue. The Revenue has grown by 6.67% in the last year.
Measured over the past years, CRI shows a small growth in Revenue. The Revenue has been growing by 3.10% on average per year.
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
CRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.48% yearly.
CRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.12% yearly.
EPS Next Y46.67%
EPS Next 2Y52.98%
EPS Next 3Y32.48%
EPS Next 5YN/A
Revenue Next Year3.88%
Revenue Next 2Y5.15%
Revenue Next 3Y4.12%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 81.83, the valuation of CRI can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CRI indicates a slightly more expensive valuation: CRI is more expensive than 70.59% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. CRI is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 9.50, the valuation of CRI can be described as very reasonable.
82.35% of the companies in the same industry are more expensive than CRI, based on the Price/Forward Earnings ratio.
CRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.43, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 81.83 | ||
| Fwd PE | 9.5 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CRI is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CRI is valued a bit more expensive than the industry average as 64.71% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 76.38 | ||
| EV/EBITDA | 7.12 |
4.3 Compensation for Growth
CRI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CRI's earnings are expected to grow with 32.48% in the coming years.
PEG (NY)1.75
PEG (5Y)N/A
EPS Next 2Y52.98%
EPS Next 3Y32.48%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.35%, CRI has a reasonable but not impressive dividend return.
With a Dividend Yield of 1.35, CRI pays less dividend than the industry average, which is at 12.43. 82.35% of the companies listed in the same industry pay a better dividend than CRI!
Compared to an average S&P500 Dividend Yield of 2.36, CRI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.35% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
128.00% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
DP128%
EPS Next 2Y52.98%
EPS Next 3Y32.48%
EPA:CRI (11/13/2025, 4:26:13 PM)
9.82
+0.04 (+0.41%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners5.35%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap244.42M
Revenue(TTM)727.50M
Net Income(TTM)2.50M
Analysts75
Price Target13.09 (33.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.35% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP128%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-40.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.07%
Revenue NY rev (3m)-3.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 81.83 | ||
| Fwd PE | 9.5 | ||
| P/S | 0.34 | ||
| P/FCF | 76.38 | ||
| P/OCF | 10.45 | ||
| P/B | 0.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.12 |
EPS(TTM)0.12
EY1.22%
EPS(NY)1.03
Fwd EY10.53%
FCF(TTM)0.13
FCFY1.31%
OCF(TTM)0.94
OCFY9.57%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)1.75
PEG (5Y)N/A
Graham Number5.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROCE | 7.08% | ||
| ROIC | 5.19% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 13.23% | ||
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% | ||
| FCFM | 0.44% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Debt/EBITDA | 4.62 | ||
| Cap/Depr | 65.16% | ||
| Cap/Sales | 2.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30% | ||
| Profit Quality | 128% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.23 |
F-Score7
WACC6.4%
ROIC/WACC0.81
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y46.67%
EPS Next 2Y52.98%
EPS Next 3Y32.48%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year3.88%
Revenue Next 2Y5.15%
Revenue Next 3Y4.12%
Revenue Next 5YN/A
EBIT growth 1Y57.72%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year118.91%
EBIT Next 3Y41.15%
EBIT Next 5YN/A
FCF growth 1Y109.04%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y241.82%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
Can you provide the valuation status for COMPAGNIE CHARGEURS INVEST?
ChartMill assigns a valuation rating of 4 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Fairly Valued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
What is the financial health of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.
Can you provide the expected EPS growth for CRI stock?
The Earnings per Share (EPS) of COMPAGNIE CHARGEURS INVEST (CRI.PA) is expected to grow by 46.67% in the next year.